Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.
暂无分享，去创建一个
J. Baselga | V. Semiglazov | A. Manikhas | C. Hudis | D. Lokanatha | R. Goldfarb | S. Forenza | J. Matera | M. Rozencweig | J. Cortés | N. Azarnia | V. Semiglazov | L. Roman | A. Llombart | M. Byakhov | Javier Cortés | J. Baselga | Clifford A. Hudis